
DTC vs. DTP: Regulatory uncertainty & access challenges drive new go-to-market models
Two senators recently introduced legislation to further restrict DTC advertising, but will it matter to pharma? Many pharma brands have already shifted their Go-to-Market (GTM) models regardless of if they believe in new DTC regulations. That’s because …